OBJECTIVES: The aim of this study was to identify reasons for and predictors of readmission. BACKGROUND: Short-term readmissions have been identified as an important cause of escalating health care costs, and coronary artery bypass graft (CABG) surgery is 1 of the most expensive procedures. METHODS: We retrospectively analyzed 30-day readmissions for 33,936 New York State patients who underwent CABG surgery between January 1, 2005, and November 30, 2007. The main reasons for readmission (principal diagnoses) and the significant independent predictors of readmission were identified. The hospital-level relationship between risk-adjusted mortality rate and risk-adjusted readmission rate was explored to determine the value of readmission rate as a complementary measure of quality. RESULTS: The most common reasons for readmission were post-operative infection (16.9%), heart failure (12.8%), and "other complications of surgical and medical care" (9.8%). Increasing age, female sex, African-American race, higher body mass index, numerous comorbidities, 2 post-operative complications (renal failure and unplanned cardiac reoperation), Medicare or Medicaid status, discharges to a skilled nursing facility, saphenous vein grafts, and longer lengths of stay were all associated with higher rates of readmission. The correlation between the risk-adjusted 30-day readmission rate of hospitals and risk-adjusted in-hospital/30-day mortality rate was 0.32 (p = 0.047). The range across hospitals in the readmission rate was from 8.3% to 21.1%. CONCLUSIONS: The 30-day readmission rate for CABG surgery remains high, despite decreases in short-term mortality. Patients with any of the numerous risk factors for readmission should be closely monitored. Hospital readmission rates are not highly correlated with mortality rates and might serve as an independent quality measure.
OBJECTIVES: The aim of this study was to identify reasons for and predictors of readmission. BACKGROUND: Short-term readmissions have been identified as an important cause of escalating health care costs, and coronary artery bypass graft (CABG) surgery is 1 of the most expensive procedures. METHODS: We retrospectively analyzed 30-day readmissions for 33,936 New York State patients who underwent CABG surgery between January 1, 2005, and November 30, 2007. The main reasons for readmission (principal diagnoses) and the significant independent predictors of readmission were identified. The hospital-level relationship between risk-adjusted mortality rate and risk-adjusted readmission rate was explored to determine the value of readmission rate as a complementary measure of quality. RESULTS: The most common reasons for readmission were post-operative infection (16.9%), heart failure (12.8%), and "other complications of surgical and medical care" (9.8%). Increasing age, female sex, African-American race, higher body mass index, numerous comorbidities, 2 post-operative complications (renal failure and unplanned cardiac reoperation), Medicare or Medicaid status, discharges to a skilled nursing facility, saphenous vein grafts, and longer lengths of stay were all associated with higher rates of readmission. The correlation between the risk-adjusted 30-day readmission rate of hospitals and risk-adjusted in-hospital/30-day mortality rate was 0.32 (p = 0.047). The range across hospitals in the readmission rate was from 8.3% to 21.1%. CONCLUSIONS: The 30-day readmission rate for CABG surgery remains high, despite decreases in short-term mortality. Patients with any of the numerous risk factors for readmission should be closely monitored. Hospital readmission rates are not highly correlated with mortality rates and might serve as an independent quality measure.
Authors: Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney Journal: J Am Coll Surg Date: 2012-06-21 Impact factor: 6.113
Authors: Joshua M Rosenblum; Brendan P Lovasik; John C Hunting; Jose Binongo; Michael E Halkos; Bradley G Leshnower; Jeffrey S Miller; Omar M Lattouf; Robert A Guyton; William B Keeling Journal: Gen Thorac Cardiovasc Surg Date: 2019-02-08
Authors: Benedict Morath; Tanja Mayer; Alexander Francesco Josef Send; Torsten Hoppe-Tichy; Walter Emil Haefeli; Hanna Marita Seidling Journal: Br J Clin Pharmacol Date: 2017-06-14 Impact factor: 4.335
Authors: E A King; L M Kucirka; M A McAdams-DeMarco; A B Massie; F Al Ammary; R Ahmed; M E Grams; D L Segev Journal: Am J Transplant Date: 2015-10-16 Impact factor: 8.086
Authors: William S Weintraub; Zaher Fanari; Daniel Elliott; Jennifer Ostertag-Stretch; Ann Muther; Margaret Lynahan; Roger Kerzner; Tabassum Salam; Herbert Scherrer; Sharon Anderson; Carla A Russo; Paul Kolm; Terri H Steinberg Journal: Cardiovasc Revasc Med Date: 2017-07-03
Authors: Samuel Torres Landa; Jordana B Cohen; Robert A Swendiman; Chris Wirtalla; Daniel T Dempsey; Kristoffel R Dumon Journal: J Gastrointest Surg Date: 2018-07-31 Impact factor: 3.452
Authors: Justin P Fox; Lisa G Suter; Karen Wang; Yongfei Wang; Harlan M Krumholz; Joseph S Ross Journal: Ann Thorac Surg Date: 2013-05-21 Impact factor: 4.330
Authors: Alexander Iribarne; Helena Chang; John H Alexander; A Marc Gillinov; Ellen Moquete; John D Puskas; Emilia Bagiella; Michael A Acker; Mary Lou Mayer; T Bruce Ferguson; Sandra Burks; Louis P Perrault; Stacey Welsh; Karen C Johnston; Mandy Murphy; Joseph J DeRose; Alexis Neill; Edlira Dobrev; Kim T Baio; Wendy Taddei-Peters; Alan J Moskowitz; Patrick T O'Gara Journal: Ann Thorac Surg Date: 2014-08-28 Impact factor: 4.330